{"id":9592,"date":"2021-06-17T15:54:16","date_gmt":"2021-06-17T05:54:16","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?p=9592"},"modified":"2021-06-17T15:54:16","modified_gmt":"2021-06-17T05:54:16","slug":"atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021","status":"publish","type":"post","link":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/","title":{"rendered":"Tuy\u00ean b\u1ed1 c\u1ee7a ATAGI v\u1ec1 c\u00e1c khuy\u1ebfn ngh\u1ecb s\u1eeda \u0111\u1ed5i v\u1ec1 vi\u1ec7c s\u1eed d\u1ee5ng V\u1eafc xin COVID-19 AstraZeneca, ng\u00e0y 17 th\u00e1ng 6 n\u0103m 2021"},"content":{"rendered":"

ATAGI \u0111\u00e3 s\u1eeda \u0111\u1ed5i c\u00e1c khuy\u1ebfn ngh\u1ecb v\u1ec1 ti\u00eam ch\u1ee7ng COVID-19 t\u1ea1i \u00dac.<\/p>\n

Do r\u1ee7i ro cao h\u01a1n v\u00e0 m\u1ee9c \u0111\u1ed9 nghi\u00eam tr\u1ecdng c\u1ee7a huy\u1ebft kh\u1ed1i v\u1edbi h\u1ed9i ch\u1ee9ng gi\u1ea3m ti\u1ec3u c\u1ea7u (TTS)<\/a> li\u00ean quan \u0111\u1ebfn vi\u1ec7c s\u1eed d\u1ee5ng COVID-19 AstraZeneca, Comirnaty\u2122 hi\u1ec7n l\u00e0 v\u1eafc xin COVID-19 \u0111\u01b0\u1ee3c \u01b0u ti\u00ean cho nh\u1eefng ng\u01b0\u1eddi t\u1eeb 16-59 tu\u1ed5i. Do nguy c\u01a1 d\u1eabn \u0111\u1ebfn h\u1eadu qu\u1ea3 nghi\u00eam tr\u1ecdng li\u00ean quan \u0111\u1ebfn b\u1ec7nh COVID-19 \u0111\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi t\u1eeb 60 tu\u1ed5i tr\u1edf l\u00ean, l\u1ee3i \u00edch c\u1ee7a vi\u1ec7c ti\u00eam v\u1eafc-xin trong vi\u1ec7c ng\u0103n ng\u1eeba b\u1ec7nh l\u1edbn h\u01a1n nguy c\u01a1 ph\u00e1t tri\u1ec3n TTS.<\/p>\n

Nh\u1eefng ng\u01b0\u1eddi d\u01b0\u1edbi 60 tu\u1ed5i \u0111\u00e3 nh\u1eadn li\u1ec1u COVID-19 AstraZeneca \u0111\u1ea7u ti\u00ean m\u00e0 kh\u00f4ng c\u00f3 b\u1ea5t k\u1ef3 t\u00e1c d\u1ee5ng ph\u1ee5 nghi\u00eam tr\u1ecdng n\u00e0o (v\u00ed d\u1ee5: s\u1ed1c ph\u1ea3n v\u1ec7 ho\u1eb7c TTS) n\u00ean ti\u1ebfp t\u1ee5c nh\u1eadn li\u1ec1u th\u1ee9 hai.<\/p>\n

\u0110\u1ec3 bi\u1ebft th\u00eam th\u00f4ng tin xin vui l\u00f2ng tham kh\u1ea3o li\u00ean k\u1ebft d\u01b0\u1edbi \u0111\u00e2y:<\/p>\n

Tuy\u00ean b\u1ed1 c\u1ee7a ATAGI v\u1ec1 c\u00e1c khuy\u1ebfn ngh\u1ecb s\u1eeda \u0111\u1ed5i v\u1ec1 vi\u1ec7c s\u1eed d\u1ee5ng V\u1eafc xin COVID-19 AstraZeneca, ng\u00e0y 17 th\u00e1ng 6 n\u0103m 2021<\/a><\/p>\n

 <\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

Due to a higher risk and severity of thrombosis with thrombycytopenia syndrome (TTS) related to the use of COVID-19 AstraZeneca, Comirnaty\u2122 is now the preferred COVID-19 vaccine for individuals aged 16-59 years. Due to the risk of severe outcomes related to COVID-19 disease for individuals aged 60 years and over, the benefits of vaccination in preventing disease outweighs the risk of developing TTS.<\/p>","protected":false},"author":375,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[87,8,10],"tags":[],"class_list":["post-9592","post","type-post","status-publish","format-standard","hentry","category-news","category-covid-19","category-external"],"acf":[],"yoast_head":"\nATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021 - The Melbourne Vaccine Education Centre (MVEC)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021 - The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"og:description\" content=\"Due to a higher risk and severity of thrombosis with thrombycytopenia syndrome (TTS) related to the use of COVID-19 AstraZeneca, Comirnaty\u2122 is now the preferred COVID-19 vaccine for individuals aged 16-59 years. Due to the risk of severe outcomes related to COVID-19 disease for individuals aged 60 years and over, the benefits of vaccination in preventing disease outweighs the risk of developing TTS.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-17T05:54:16+00:00\" \/>\n<meta name=\"author\" content=\"Rachael McGuire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rachael McGuire\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\\\/\"},\"author\":{\"name\":\"Rachael McGuire\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/571925ba39f95adf6ba3463422a752d7\"},\"headline\":\"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021\",\"datePublished\":\"2021-06-17T05:54:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\\\/\"},\"wordCount\":139,\"commentCount\":0,\"articleSection\":[\"Show all\",\"COVID-19\",\"External News\"],\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\\\/\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\\\/\",\"name\":\"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021 - The Melbourne Vaccine Education Centre (MVEC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\"},\"datePublished\":\"2021-06-17T05:54:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/571925ba39f95adf6ba3463422a752d7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\",\"name\":\"The Melbourne Vaccine Education Centre (MVEC)\",\"description\":\"Find all your vaccine related infos here.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/571925ba39f95adf6ba3463422a752d7\",\"name\":\"Rachael McGuire\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/vi\\\/author\\\/rachael-mcguire\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021 - The Melbourne Vaccine Education Centre (MVEC)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/","og_locale":"vi_VN","og_type":"article","og_title":"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021 - The Melbourne Vaccine Education Centre (MVEC)","og_description":"Due to a higher risk and severity of thrombosis with thrombycytopenia syndrome (TTS) related to the use of COVID-19 AstraZeneca, Comirnaty\u2122 is now the preferred COVID-19 vaccine for individuals aged 16-59 years. Due to the risk of severe outcomes related to COVID-19 disease for individuals aged 60 years and over, the benefits of vaccination in preventing disease outweighs the risk of developing TTS.","og_url":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/","og_site_name":"The Melbourne Vaccine Education Centre (MVEC)","article_published_time":"2021-06-17T05:54:16+00:00","author":"Rachael McGuire","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Rachael McGuire","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"1 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/#article","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/"},"author":{"name":"Rachael McGuire","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/571925ba39f95adf6ba3463422a752d7"},"headline":"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021","datePublished":"2021-06-17T05:54:16+00:00","mainEntityOfPage":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/"},"wordCount":139,"commentCount":0,"articleSection":["Show all","COVID-19","External News"],"inLanguage":"vi","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mvec.mcri.edu.au\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/","url":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/","name":"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021 - The Melbourne Vaccine Education Centre (MVEC)","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/#website"},"datePublished":"2021-06-17T05:54:16+00:00","author":{"@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/571925ba39f95adf6ba3463422a752d7"},"breadcrumb":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mvec.mcri.edu.au\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-revised-recommendations-on-the-use-of-covid-19-vaccine-astrazeneca-17-june-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mvec.mcri.edu.au\/"},{"@type":"ListItem","position":2,"name":"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021"}]},{"@type":"WebSite","@id":"https:\/\/mvec.mcri.edu.au\/#website","url":"https:\/\/mvec.mcri.edu.au\/","name":"Trung t\u00e2m gi\u00e1o d\u1ee5c v\u1eafc xin Melbourne (MVEC)","description":"T\u00ecm t\u1ea5t c\u1ea3 c\u00e1c th\u00f4ng tin li\u00ean quan \u0111\u1ebfn v\u1eafc-xin c\u1ee7a b\u1ea1n \u1edf \u0111\u00e2y.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mvec.mcri.edu.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Person","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/571925ba39f95adf6ba3463422a752d7","name":"Rachel McGuire","url":"https:\/\/mvec.mcri.edu.au\/vi\/author\/rachael-mcguire\/"}]}},"modified_by":"Rachael McGuire","_links":{"self":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/9592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/users\/375"}],"replies":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/comments?post=9592"}],"version-history":[{"count":0,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/9592\/revisions"}],"wp:attachment":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/media?parent=9592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/categories?post=9592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/tags?post=9592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}